BCT Expo 2026 Puts Net Zero at the Heart of Construction & Mining

BCT Expo 2026 Puts Net Zero at the Heart of Construction & Mining

150+ Global Brands, Smart Technologies and Low-Carbon Solutions Set to Shape the Industry's Sustainable Future BANGKOK, Sept. 11, 2026 /PRNewswire/ -- IMPACT Exhibition Management Co., Ltd., together with its public- and private-sector partners, has...

Fringe events at Automechanika Jakarta empower, connect and immerse participants in Indonesia's automotive industry

Fringe events at Automechanika Jakarta empower, connect and immerse participants in Indonesia's automotive industry

JAKARTA, Indonesia, Sept. 11, 2026 /PRNewswire/ -- Automechanika Jakarta is making its debut from 24 to 27 September 2026 at Nusantara International Convention Exhibition (NICE). Bringing together more than 300 exhibitors from 16 represented markets...

Great Place To Work™ Greater China Celebrates the Best Workplaces™ in Taiwan 2026

Great Place To Work™ Greater China Celebrates the Best Workplaces™ in Taiwan 2026

Inspiration — the strategic pillar of high ‑ trust leadership that shapes culture, reinforces trust, and aligns collective purpose. TAIPEI, Sept. 11, 2026 /PRNewswire/ -- On Sept. 10, Great Place To Work™ proudly hosted the Best Workplaces™ in...

Leifras Announces Plan to Enter the Non-Life Insurance Agency Business

Leifras Announces Plan to Enter the Non-Life Insurance Agency Business

Expanding Services to Address Growing Insurance Needs Associated with the Regional Transition of School Club Activities; Building a Framework to Provide Insurance Support to Municipalities, Schools and Other Organizations while Ensuring Legal and...

APR Takes Flagship Brand Medicube on U.S. and European Pop-Up Tour

APR Takes Flagship Brand Medicube on U.S. and European Pop-Up Tour

APR launches "Medicube Wellness Club X2" pop-ups across New York, Los Angeles, London, and Paris this fall, accelerating its market presence and consumer engagement across Western regions The multi-city tour spotlights the newly launched AGE-R...

Taiyo Holdings Launches Next-generation Semiconductor-packaging Material "FPIM Series," Achieving Its First Three-layer RDL Formation with 700-nm CD on 12-inch Wafers

Taiyo Holdings Launches Next-generation Semiconductor-packaging Material "FPIM Series," Achieving Its First Three-layer RDL Formation with 700-nm CD on 12-inch Wafers

- Paper Presented at IEEE ESTC 2026, International Conference on Semiconductor- and Electronic Device-packaging Technologies and Related Materials - TOKYO, Sept. 10, 2026 /PRNewswire/ -- Taiyo Holdings Co., Ltd. (Securities code: 4626; hereinafter...

Tulip Unveils Global Imaging Patent Licensing Program

Tulip Unveils Global Imaging Patent Licensing Program

Tulip Imaging provides access to more than 125,000 patents from Canon, Sony, Huawei, and OPPO covering foundational image and information processing technologies LONDON, Sept. 10, 2026 /PRNewswire/ -- Tulip Licensing Ltd today announced the launch...

Pop Culture Group Co., Ltd Announces 15 for 1 Share Consolidation

Pop Culture Group Co., Ltd Announces 15 for 1 Share Consolidation

XIAMEN, China, Sept. 10, 2026 /PRNewswire/ -- Pop Culture Group Co., Ltd (NASDAQ: CPOP) (the "Company"), today announced that it will effect a share consolidation of its Class A ordinary shares of par value US$0.1 each (the "Class A Ordinary...

Frost & Sullivan to Convene More Than 300 Business, Technology and Innovation Leaders at GIL Japan 2026

Frost & Sullivan to Convene More Than 300 Business, Technology and Innovation Leaders at GIL Japan 2026

Tokyo summit will explore how organisations can turn geopolitical risk, resource constraints and market fragmentation into competitive advantage TOKYO, Sept. 10, 2026 /PRNewswire/ -- Frost & Sullivan today announced that the Growth, Innovation...

First Participant Dosed in First-in-Human Phase 1 Study of GZC8072, a Novel Ultra-Long-Acting Once-Weekly Oral Peptide GLP-1 RA

First Participant Dosed in First-in-Human Phase 1 Study of GZC8072, a Novel Ultra-Long-Acting Once-Weekly Oral Peptide GLP-1 RA

BEIJING and BRIDGEWATER, Mass., Sept. 9, 2026 /PRNewswire/ -- Gan&Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan&Lee) announced that the first participant has been dosed in a First-In-Human (FIH) Phase 1 study of GZC8072...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 151
  • menu
    menu